Cold Spring Harbor Laboratory: How Cancer Metabolism Could Be Key for New Therapies
February 06, 2020
February 06, 2020
COLD SPRING HARBOR, New York, Feb. 6 -- The Cold Spring Harbor Laboratory issued the following news:
Biochemist Michael Lukey joins Cold Spring Harbor Laboratory (CSHL) as the newest addition to its National Cancer Institute-designated Cancer Center. Lukey studies the metabolic reprogramming events that cancer cells undergo to feed tumor growth. He works on identifying vulnerabilities in these metabolic processes that can be targets for cancer therapy, including when breast cancer m . . .
Biochemist Michael Lukey joins Cold Spring Harbor Laboratory (CSHL) as the newest addition to its National Cancer Institute-designated Cancer Center. Lukey studies the metabolic reprogramming events that cancer cells undergo to feed tumor growth. He works on identifying vulnerabilities in these metabolic processes that can be targets for cancer therapy, including when breast cancer m . . .